Tirzepatide vs. Semaglutide: Weight Loss, Side Effects, Cost, and Results
If you are looking into medical weight loss, you have probably heard about semaglutide and tirzepatide.
Both medications can reduce hunger, help control blood sugar, and support significant weight loss. However, they do not work in exactly the same way, and one medication may be a better fit for one person than another.
So, what is the real difference between semaglutide and tirzepatide?
Here is what current research tells us about tirzepatide vs. semaglutide for weight loss, including results, side effects, costs, risks, and other factors to consider when choosing a treatment.
What Are Semaglutide and Tirzepatide?
Semaglutide and tirzepatide are prescription medications used for different metabolic conditions, including weight management and type 2 diabetes.
What Is Semaglutide?
Semaglutide is the active medication found in products such as Wegovy, Ozempic, and Rybelsus.
Wegovy is FDA approved for chronic weight management in eligible patients. Ozempic and Rybelsus contain the same active medication but have different FDA-approved uses.
When comparing semaglutide and tirzepatide specifically for weight management, Wegovy is generally the most appropriate semaglutide product to consider.
What Is Tirzepatide?
Tirzepatide is the active medication found in Zepbound and Mounjaro.
Zepbound is FDA approved for chronic weight management in eligible adults, while Mounjaro is approved for adults with type 2 diabetes.
For weight management, Wegovy and Zepbound provide the most useful comparison.
How Do Semaglutide and Tirzepatide Work?
Although both medications influence hormones involved in appetite and metabolism, they work somewhat differently.
How Semaglutide Works
Semaglutide works primarily on a hormone pathway called GLP-1, or glucagon-like peptide-1.
GLP-1 plays a role in regulating:
Appetite
Blood sugar
Insulin
Feelings of fullness
How quickly food moves through the stomach
By acting on this pathway, semaglutide can help people feel full sooner, experience less hunger, and consume fewer calories.
How Tirzepatide Works
Tirzepatide works on two hormone pathways: GLP-1 and GIP.
Both hormones influence appetite, blood sugar, insulin, and food intake.
Because tirzepatide acts on two pathways instead of one, researchers have been particularly interested in whether it can produce greater weight loss than semaglutide.
We now have a direct comparison.
Tirzepatide vs. Semaglutide: Which Leads to More Weight Loss?
One of the most important studies comparing these medications is the SURMOUNT-5 clinical trial.
The study directly compared tirzepatide with semaglutide in 751 adults with obesity who did not have type 2 diabetes.
Tirzepatide vs. Semaglutide Weight Loss Results
After 72 weeks, average weight loss was:
Tirzepatide: 20.2%
Semaglutide: 13.7%
People taking tirzepatide also experienced a greater reduction in waist circumference.
Additionally, more participants taking tirzepatide achieved weight-loss milestones of 10%, 15%, 20%, and 25% or more of their starting body weight.[1]
This study is especially important because tirzepatide and semaglutide were tested directly against each other under the same clinical trial.
However, these percentages are averages.
They do not mean that everyone taking tirzepatide will lose 20.2% of their body weight or that everyone taking semaglutide will lose 13.7%.
Individual results can vary significantly.
Does Semaglutide Still Work Well for Weight Loss?
Yes. Semaglutide has extensive research supporting its effectiveness for weight management.
Semaglutide Weight Loss Results
In the STEP 1 clinical trial, adults taking semaglutide 2.4 mg lost an average of 14.9% of their starting body weight after 68 weeks.
Participants receiving a placebo lost approximately 2.4%.[2]
About 86% of participants taking semaglutide lost at least 5% of their starting weight.
Tirzepatide Weight Loss Results
Tirzepatide also demonstrated significant results in the earlier SURMOUNT-1 trial.
After 72 weeks, average weight loss was approximately:
15% with tirzepatide 5 mg
19.5% with tirzepatide 10 mg
20.9% with tirzepatide 15 mg[3]
The research shows that both semaglutide and tirzepatide can be effective weight-management medications when they are medically appropriate.
Why Weight Loss Results Can Differ From Person to Person
Clinical trials give us valuable averages, but they cannot predict exactly how much weight an individual person will lose.
Factors That May Affect GLP-1 Weight Loss Results
Your response to treatment can depend on factors such as:
Medication dose and how well you tolerate it
How long you use the medication
Other medications you take
Existing medical conditions
Nutrition and eating habits
Physical activity
Sleep
Genetics
Individual metabolism
This is why the medication associated with the highest average weight loss is not automatically the best medication for every patient.
Do Semaglutide and Tirzepatide Reduce “Food Noise”?
Some patients taking GLP-1 medications report experiencing less of what is commonly called “food noise.”
What Is Food Noise?
Food noise can describe frequently thinking about food, experiencing persistent cravings, or feeling strongly driven to eat even when you may not physically need food.
Many patients describe a reduction in these thoughts while using GLP-1 medications.
However, “food noise” is not a medical diagnosis, and there is not enough evidence to promise that tirzepatide will reduce food noise faster or more effectively than semaglutide for every person.
What Are the Most Common Semaglutide and Tirzepatide Side Effects?
Semaglutide and tirzepatide share many of the same common side effects.
Common GLP-1 Medication Side Effects
These may include:
Nausea
Constipation
Diarrhea
Vomiting
Indigestion
Stomach discomfort
Decreased appetite
Fatigue in some patients
Side effects may be more noticeable when treatment first begins or when the medication dose increases.
This is one reason these medications are typically increased gradually rather than immediately starting at a higher dose.
Taking a higher dose faster does not necessarily mean better weight-loss results, and it may make side effects more difficult to manage.
What About “Ozempic Face”?
“Ozempic face” is a popular social media term, but it is not a medical diagnosis.
What Causes Facial Changes During Weight Loss?
The term usually refers to changes in facial appearance after significant weight loss, such as:
Reduced facial fullness
More prominent facial features
Loose or sagging skin
These changes are not unique to Ozempic or semaglutide.
They can occur after significant weight loss from medication, bariatric surgery, dietary changes, or other weight-loss methods.
This is another reason medical weight management should focus on more than simply lowering the number on the scale.
Adequate protein intake, balanced nutrition, strength training when appropriate, hydration, and protecting lean muscle mass can all be important parts of a comprehensive weight-management plan.
Are There Serious Risks With Semaglutide or Tirzepatide?
Both medications have important warnings and are not appropriate for everyone.
Thyroid Tumor Warning
FDA prescribing information for these medications includes a boxed warning related to thyroid C-cell tumors observed in animal studies.
They should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).[4,5]
Other Potential Risks
Other possible risks may include:
Pancreatitis
Gallbladder problems
Severe gastrointestinal problems
Dehydration-related kidney problems
Low blood sugar in certain patients
A healthcare provider should review your medical history, current medications, pregnancy plans, and other individual risk factors before treatment begins.
Tirzepatide vs. Semaglutide Cost: Which One Costs Less?
There is no single answer to whether tirzepatide or semaglutide is less expensive.
What Determines the Cost of GLP-1 Medications?
What a patient actually pays can depend on:
Insurance coverage
Employer benefits
Manufacturer savings programs
Medication and dose
Pharmacy
Eligibility for self-pay programs
An insurance plan may cover one medication but not another. Some insurance plans may not cover medications prescribed specifically for weight management at all.
Manufacturer savings programs and self-pay options can also change.
Because pricing and coverage frequently change, it is best to check current costs when you are ready to begin treatment rather than relying on an older price found online.
What About Compounded Semaglutide and Tirzepatide?
Compounded semaglutide and tirzepatide are not FDA-approved medications.
During medication shortages, federal rules allowed certain compounding under specific conditions.
The FDA announced that the tirzepatide injection shortage was resolved in December 2024 and the semaglutide injection shortage was resolved in February 2025.[6,7]
Are Compounded GLP-1 Medications Still Available?
Compounding may still be appropriate in certain circumstances when a patient’s medical needs cannot be met by an FDA-approved medication and when permitted under current law.
However, compounded medication should not be described as:
“Generic Ozempic”
“Generic Wegovy”
“Generic Mounjaro”
“Generic Zepbound”
The FDA has also reported dosing concerns involving some compounded GLP-1 medications.[8]
Patients using compounded medications should understand:
Who is prescribing the medication
Which pharmacy is preparing it
How the medication should be stored
Exactly how the prescribed dose should be measured and administered
Semaglutide vs. Tirzepatide: Which Medication Is Better?
If we look specifically at the SURMOUNT-5 trial, tirzepatide produced greater average weight loss than semaglutide at the doses studied.[1]
However, that does not mean tirzepatide is automatically the better medication for everyone.
Factors to Consider When Choosing a Weight Loss Medication
The decision may also depend on:
Your medical history
Previous response to weight-loss medications
Medication side effects and tolerability
Other medications you take
Diabetes and metabolic health
Insurance coverage
Out-of-pocket cost
Personal treatment goals
Pregnancy plans
Long-term sustainability
For some people, tirzepatide may be the better option.
For others, semaglutide may make more sense.
Some patients may also benefit from an entirely different treatment plan.
The right approach should be based on an individual medical evaluation rather than weight-loss percentages alone.
Weight Management Is About More Than Medication
GLP-1 medications can be powerful weight-management tools, but medication is only one part of the process.
Why the Number on the Scale Doesn’t Tell the Whole Story
The scale cannot tell you whether you are losing primarily body fat or also losing significant muscle mass.
It cannot tell you whether you are:
Eating enough protein
Staying adequately hydrated
Maintaining strength and lean muscle
Meeting important nutritional needs
Developing habits that support long-term health
That is why a comprehensive medical weight-management program should involve more than simply writing a prescription.
The Vital Bloom Approach to Medical Weight Management
At Vital Bloom Concierge Medical Care, we look beyond the number on the scale.
We consider your medical history, weight-loss goals, nutrition, metabolic health, current medications, side effects, muscle preservation, lifestyle, treatment costs, and how your body is responding throughout the process.
A Personalized Approach to GLP-1 Weight Loss
When GLP-1 therapy is medically appropriate, medication becomes one part of a larger, individualized treatment plan.
The goal is not simply to lose weight.
The goal is to lose weight in a way that supports your overall health, protects your strength, and gives you a realistic path forward.
References
Aronne LJ, Bade Horn D, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine. 2025;393:26-36. doi:10.1056/NEJMoa2416394.
Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989-1002. doi:10.1056/NEJMoa2032183.
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205-216. doi:10.1056/NEJMoa2206038.
U.S. Food and Drug Administration. Current prescribing information for ZEPBOUND, tirzepatide injection.
U.S. Food and Drug Administration. Current prescribing information for WEGOVY, semaglutide injection.
U.S. Food and Drug Administration. Updates concerning the tirzepatide injection shortage and compounding policies.
U.S. Food and Drug Administration. Updates concerning the semaglutide injection shortage and compounding policies.
U.S. Food and Drug Administration. FDA concerns regarding unapproved GLP-1 medications used for weight loss.
Medical Disclaimer
This article is for educational purposes only and does not replace medical advice. Semaglutide, tirzepatide, and other prescription medications should only be used after an appropriate medical evaluation by a qualified healthcare professional. Results, risks, costs, insurance coverage, and medication availability vary by patient and may change over time.
Comments